magnolol has been researched along with Metastase in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, J; Wen, H; Zhou, S | 1 |
| Hwang, ES; Park, KK | 1 |
| Cheng, YT; Chuang, TC; Fang, GS; Hsu, SC; Ou, CC; Shao, WS; Wang, V; Wu, K | 1 |
3 other study(ies) available for magnolol and Metastase
| Article | Year |
|---|---|
Induction of apoptosis by magnolol via the mitochondrial pathway and cell cycle arrest in renal carcinoma cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Lignans; Membrane Potential, Mitochondrial; Mitochondria; Neoplasm Metastasis; Reactive Oxygen Species | 2019 |
Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells.
Topics: Biphenyl Compounds; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lignans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Neoplasm Metastasis; Prostatic Neoplasms | 2010 |
Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Topics: Biphenyl Compounds; Caspase 3; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclin D1; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lignans; Neoplasm Metastasis; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2011 |